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Abstract
Many terminal human diseases are caused by mutations affecting mitochondrial functioning.
Mitochondria are essential organelles responsible for producing cellular energy, adenosine
triphosphate (ATP) via oxidative phosphorylation (OXPHOS) at mitochondrial electron
transport chains (ETC). Proper ETC functioning relies on maintenance of the electrochemical
gradient essential for energy production, known as mitochondrial membrane potential (∆ψM).
The inner mitochondrial membrane is the site of the ETC and is most closely in contact with the
enzymatic processes occurring within the mitochondrial matrix. Mutations affecting protein
components of the ETC are especially troublesome for organelle health. ETC mutants commonly
express altered ∆ψM, as well as increased production of damaging reactive oxygen species
(ROS), which are hypothesized to cause genomic damage and lasting mutation. The nematode C.
elegans is a practical model organism for investigating the phenotypic and genomic consequences
of ETC mutations. Despite expressing higher levels of damaging ROS, the ETC protein complex 1
mutant, gas-1, expresses heritable mtDNA and nDNA mutation rates identical to those of wild type
animals. I am using a mitochondria-targeted dye and fluorescence microscopy to quantify and
compare ∆ψM levels of the gas-1 mutant and wild type animals. This work will provide a novel
phenotypic characterization of this mutant and indicate whether decreased metabolic activity (e.g.,
reduced reliance on OXPHOS) is occurring in gas-1, and perhaps conferring protection from
genomic degradation. Based on gas-1’s characteristically low ATP production and high ROS
production, I expect that ∆ψM will be higher in gas-1 as compared to wild type levels.

Introduction
Mitochondria are arguably the most important organelle to cellular health and performance because
they are the site of bioenergy metabolism for the entire cell. Glucose is digested and sent to the
Citric Acid Cycle (TCA) located in the mitochondrial cytoplasm in the form of pyruvate, which is
then metabolized to provide electrons in the form of NADH and FADH2 for use in oxidative
phosphorylation (OXPHOS) occurring at the mitochondrial electron transport chain (ETC). The ETC
is comprised of a series of proteins, organized into supercomplexes, located along the inner
mitochondrial membrane. The movement of electrons through the complexes of the ETC produces
more cellular energy in the form of ATP than glycolysis and the tricarboxylic acid cycle (TCA) cycle
combined, and is powered by the constant movement of ions across the inner membrane, known
as an electrochemical gradient, or the inner mitochondrial membrane potential (∆ψM).
Mutations in both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) can be responsible for
coded dysfunction in a mitochondrion. Mutations affecting the ETC will consequently inhibit the
production of ATP via OXPHOS and possibly other important regulatory functions of mitochondria.
In addition to its central role in ETC and cellular function, maintenance of ∆ψM is crucial for the
process of mitochondrial fusion, and excessive fragmentation (fission) of mitochondria results when
∆ψM is disrupted due to overwhelming proton translocator activity (Legros, 2002). Cycles of
mitochondrial fission and fusion are crucial to overall cell health; however, only mitochondrial
fusion is dependent upon ∆ψM (Legros, 2002). Because mitochondrial function is crucial for energy
metabolism, dysfunctions within these organelles can lead to a broad range of diseases in animals,
including Parkinson’s disease in humans (Celardo, Martins, and Gandhi, 2014).
Complex 1 of the ETC is specifically responsible for the oxidation of NADH to lone electrons and
protons and creating the initial proton gradient along the inner mitochondrial membrane, which
initiates energy production through OXPHOS. This movement of ions is the main source of reactive
oxygen species (ROS) due to electron leakage onto molecular oxygen, which is ever present due to
the nature of this process (Hicks, Denver, and Estes, 2013). Although some ROS are critically
important for molecular signaling, at high levels they are damaging to proteins, can cause
morphological changes in mitochondria, disrupt ∆ψM, delay organismal development, and cause
oxidative damage to DNA and lasting mutation (Shibuya and Tsujimoto, 2012). The idea that ROSinduced oxidative damage is an important source of somatic (non-gamete) or heritable (germline)
mutation in nDNA or mtDNA genomes is controversial (Griffiths et al., 2000).
Altered metabolic processes were first observed in colorectal cancer cells (Warburg et al., 1956).
The Warburg Effect is a phenomenon characterized by a shift in metabolism from primary use of
OXPHOS to a less oxidatively stressful (i.e., lower ROS producing) but much less energetically
efficient mixture of aerobic glycolysis and OXPHOS, which benefits rapidly proliferating cells (1956;
Lunt and VanderHeiden, 2011). Ericson et al. (2012) measured the frequency of random de novo
single base substitutions in the mtDNA of human colorectal cancer cells and discovered that tumor
tissue had fewer C:G to T:A transition mutations (known to be associated with oxidative damage)
compared to healthy colorectal tissue cells. Ericson et al. (2012) also showed that this decrease in
mutation frequency was coupled with a metabolic shift from OXPHOS to anaerobic glycolysis, which
was not witnessed in healthy colorectal cells. These findings suggest that the stability of the
mitochondrial genome is increased in cancer compared to healthy cells, as a result of a decrease in
ROS related mtDNA damage. Inhibited or suppressed energy production has also been observed in
a wide variety of other diseases, including diabetes and neurodegenerative disorders (DeBerardinis,
2012). However, whether and to what extent altered or depressed metabolism can protect
organisms from heritable (germline) mutations has not been studied.
C. elegans nematodes are becoming an increasingly important model system for studying
mitochondrial dysfunction and its relationship with energy metabolism and mutation. These

microscopic animals are easy to maintain, transparent, non-parasitic, and can be used for studying
the effects of mutation on individuals and populations with relative ease. Among several ETC
mutant alleles available for C. elegans, gas-1 (fc21) is particularly well-studied. gas-1 is a nuclear
gene and gas-1 (fc21) is a single base pair substitution that creates a hypomorphic allele in a
protein component of ETC complex 1
(http://www.wormbase.org/species/c_elegans/gene/WBGene00001520?query=gas-1#0-9e-3).
gas-1 expresses many altered physiological phenotypes such as increased dependence on ETC
complex II to maintain metabolic homeostasis, decreased growth rate, decreased fecundity, a
characteristic hypersensitivity to volatile anesthetics, increased levels of ROS, and decreased
OXPHOS abilities as compared to that of wild type (Kayser et at., 2001). Despite the fact that gas1 mutants exhibit elevated levels of damaging ROS, previous studies performed by the D. R.
Denver lab (Oregon State Univ.) have concluded that both mtDNA and nDNA mutation rates in gas1 are identical to those expressed by wild type animals (Estes pers. comm.). This result may
indicate that ROS do not affect heritable mutation rates as previously thought. Based on these and
previous findings, we believe that gas-1 is experiencing a shift in metabolism synonymous with the
Warburg Effect, and as a result, is gaining genomic protection from the mutagenic effects of high
levels of ROS by reducing its dependence on energy production via the OXPHOS pathway (c.f.,
Ericson et al., 2012).
Previous phenotyping of gas-1 has included various life-history and physiological traits (Kayser et
al., 2001; Cairo et al., 1992; Estes et al., unpubl.), and studies of gene expression (Falk et al.
2008); however, ∆ψM has not yet been characterized. Further investigation of gas-1 is necessary
to understand the effects of mutation on the ETC metabolic process, as well as the possibility of
genomic preservation by means of altered metabolic pathways. By quantifying and comparing inner
∆ψM of the mutant gas-1 to that of wild type animals, it will be possible to gain an understanding
of the effects of the gas-1 mutation on energy production in C. elegans. Because ∆ψM drives
production of ATP via OXPHOS, these data allow us to detect any change in reliance of gas-1 on
this pathway and whether a shift in metabolism may be providing genomic protection for the gas-1
mutant.
Materials & Methods
Nematode culture conditions.
The C. elegans N2 strain and the nuclear mutant, gas-1(fc21), were obtained from the
Caenorhabditis Genetics Center (University of Minnesota). Prior to experimentation, the D. R.
Denver lab (Oregon State University) generated a completely isogenic gas-1 mutant strain via 10
generations of backcrossing to the N2 strain during which the gas-1(fc21) allele was tracked by
PCR and Sanger DNA sequencing. Nematodes were thawed from a -80°C±2°C freeze and then kept
on 60mm Petri plates containing 15mL of NGM-Lite agar that had been treated with 20 µg/mL
streptomycin and seeded with OP50-1 Escherichia coli as a food source. Worms were regularly
transferred to new plates with the use of a sterilized platinum scalpel to maintain small population
sizes, avoid starvation, and decrease risk of bacterial contamination. Strains were stored in a dark,
20°C incubator. Populations no older than 30 days were used in data collection.
Fluorescence microscopy.
All methods were adapted from Hicks et al. (2012). When a sufficient number of worms from both
strains had reached adulthood, their eggs were harvested to ensure age-synchronicity during
future data collection. Age-synchronization was achieved by repeatedly rinsing samples with M9
buffer solution, dissolving adult worms with a 2:1 NaOH:bleach solution, and frequent
centrifugation to promote sedimentation of egg pellets (Hicks et al., 2012).

After the harvested eggs had matured on fresh plates for 24-58 hours, they were allowed to feed
on fluorescently dyed E. coli for 24 hours (Hicks et al., 2012). A solution of 5µL of Chloromethyl-XRosamine (CMXROS) diluted with 495µL of M9 buffer solution was used per plate. CMXROS is a
lipophillic, cationic, fluorescent dye that selectively binds to negatively charged components within
the inner mitochondrial membranes of the worms (Pendergrass, Wolf, and Poot, 2004). The worms
were then rinsed in M9 buffer solution and allowed to feed on un-dyed E. coli for 1 hour to pass
any residual dyed E. coli from their intestinal tracts. Immediately prior to imaging, all worms were
treated with a 20 mM solution of paralytic levamisole. The pharyngeal bulb of each worm was
imaged at a total magnification of 25X, with the use of a fluorescence stereoscopic dissecting
microscope (Leica MSV269). This neuromuscular organ was chosen to quantify ∆ψM because of the
large amount of localized mitochondria typically found within the boundaries of the bulb (Hicks, et
al. 2012). It is also a site that contains minimal amounts of auto-fluorescent fat deposits, which
decreases the likelihood of fluorescent interference during imaging.
Image processing and data analysis.
After images were collected, each bulb was manually encapsulated using ImageJ software (NIH).
They were then analyzed by measuring mean and maximum fluorescence values and total area of
each bulb in ImageJ. Statistical comparison of the two strains was achieved using a non-parametric
Wilcoxon chi-square approximation (first data set) or a Student’s t-test (second data set)
performed in JMP 9.0 (SAS). During image analysis, it became apparent that half of the nematodes
comprising the first data set had not matured to the young adult stage prior to imaging. Because of
this, a second set of data was collected and analyzed after the new sample had been verified to be
young adult nematodes.
Results
Two sets of data from a total of three imaging sessions that took place in July and August were
analyzed separately. Data were grouped in this fashion due to among-assay differences in
nematode developmental stage (above). The first set of data (Figure 1) indicated that gas-1
exhibited significantly lower levels of ∆ψM than the wildtype N2 strain (Wilcoxon χ²= 14.3, df = 1,
N = 133, p = 0.0002). Analysis of mean pixel intensity showed an identical pattern (data not
shown). The second set of data (Figure 2.1) showed that gas-1 trended toward higher ∆ψM levels
than the wildtype N2 strain (t = -1.44, df = 1, N = 77, p = 0.1547), although the difference was
not statistically significant. It was also observed that the wildtype strain had significantly larger
pharyngeal bulbs than those of gas-1 (t = 6.06, df = 1, N = 77, p < 0.0001) in the second data set
(Figure 2.2).

the ETC, resulting in a highly polarized
electrochemical gradient, which could also be
contributing to gas-1’s characteristically high
ROS levels and abnormally low level of ATP
production (Brand, 2000). The second set of
data also revealed that gas-1 had significantly
smaller mean pharyngeal bulb areas than
those of N2 (Figure 2.2). This large difference
in bulb size between strains could be
explained by the less efficient and less
healthy metabolism of gas-1. Similarly, it is
well-understood that the movement of the
pharynx, or pharyngeal pumping, is
recognized as a proxy for metabolic rate in C.
elegans (Collins, 2008).

Figure 1: gas-1 strain exhibits lower
levels of average maximum fluorescence
within pharyngeal bulbs stained with
MitoTracker CMXROS. Maximum
fluorescence is measured in pixel intensity, Yaxis. Error bars indicate one SEM (SD/√N).
Conclusion:
The first set of data (N =133) indicated that
gas-1 exhibited lower ∆ψM than that of
wildtype N2 (Figure 1), although upon closer
inspection it was determined that the animals
were not imaged at the appropriate young
adult stage necessary for accurate data
collection. As C. elegans reaches maturity, it
experiences a marked increase in the
numbers of mitochondria accompanied by a
shift in primary metabolic reliance from the
TCA cycle/glyoxylate cycle to OXPHOS
(Intermediary metabolism: Metabolic patterns
during development and aging: 7-9,
Wormbook, 2009); therefore, a lack of
metabolic maturity could underlie the lower
∆ψM of gas-1 compared to the wildtype N2
strain. Results from the second set of data (N
= 77), which used a verified young adult
population, suggested that the gas-1
population expressed higher levels of ∆ψM
than that of the wildtype population (Figure
2.1), although the difference was not
statistically significant. This observation could
indicate that the gas-1 mutation affecting ETC
Complex 1 prohibits dissipation of ∆ψM down

Future work will conduct additional trials
using a larger sample size will be used during
data collection, and use confocal fluorescence
microscopy, which will allow imaging of
separate focal planes at higher magnification
and increased resolution. This experiment will
also be repeated using ten mutationaccumulation (MA) lines generated from
either gas-1 or N2 (in addition to the gas-1
and N2 progenitor strains) to further explore
the possibility of a shift in metabolism from
OXPHOS to glycolysis among lines that have
accumulate mutations under genetic drift
against either the gas-1 mutant or wildtype
genetic background. Based on my
preliminary findings, I would expect that gas1 MA lines would show further increased ∆ψM

levels and would show greater variability in
have similar or lower levels of ∆ψM compared
∆ψM levels from gas-1 progenitor than N2 MA
to N2 progenitor.
lines would show compared to N2 progenitor.
In contrast, I would expect N2 MA lines to
Figure 2.1: gas-1 strain exhibits higher average
maximum fluorescence within pharyngeal bulbs
stained with MitoTracker CMXROS than that of
wildtype. Maximum fluorescence is measured in
units of pixel intensity, Y-axis. Error bars indicate one
SEM (SD/√N).

Figure 2.2: gas-1 strain exhibits smaller
pharyngeal bulb area than that of wildtype N2
when CMXROS stained organs are manually
encapsulated and measured with ImageJ data
analysis software. Pharynx area is measured in
pixels2, Y-axis. Error bars indicate one SEM (SD/√N).
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